Reach Key Decision Makers

Name	Email	Company	Title	Industry	Location
Markus Bergmann	mar************@curevac.com	CureVac	GM CureVac RNA Printer GmbH	Biotechnology	TÃ¼bingen, BW, DE
Stefan Mueller	ste***********@curevac.com	CureVac	COVID-19 Program Lead and VP Pre-Cinical Development	Biotechnology	Frankfurt, HE, DE
Markus Zettl	mar*********@curevac.com	CureVac	Vice President Oncology R and D	Biotechnology	Vienna, AT
Marco Rau	mar******@curevac.com	CureVac	General Counsel - Senior Vice President Legal and Compliance	Biotechnology	Frankfurt Am Main, Hesse, Germany
Marcus Dalton	mar**********@curevac.com	CureVac	Vice President Patents	Biotechnology	London, GB
Franz-Werner Haas	fra**************@curevac.com	CureVac	Chief Corporate Officer	Biotechnology	Stuttgart, BW, DE
Robert Tensen	rob**********@curevac.com	CureVac	Vice President Medical Affairs	Biotechnology	Frankfurt, HE, DE
Annette Schuermann	ann***************@curevac.com	CureVac	Vice President Clinical Operations	Biotechnology	Germany
Melanie Kull	mel*********@curevac.com	CureVac	Manager Intellectual Property	Biotechnology	Stuttgart, BW, DE
Till Zimmer	til********@curevac.com	CureVac	Associate Director Recruiting	Biotechnology	TÃ¼bingen, BW, DE

People